Hot Stock list for Monday, November, 5 2007

Stocks to Watch:  Gemini Explorations, Inc. (OTC BB:GXPI), InfuSystem Holdings, Inc. (OTC BB:HAPN.OB) , Ligand Pharmaceuticals Inc. (NasdaqGM:LGND) , Petaquilla Minerals Ltd. (OTC BB:PTQMF.OB) , Orchid Cellmark Inc. (NasdaqGM:ORCH)

 Featured Stock: Gemini Explorations, Inc.

(OTC BB:GXPI)

Current Price (0.10)

http://www.smallcapstockanalyst.com/

GEMINI EXPLORATIONS INC INCREASES PROJECTED CASH FLOW OF THE LOS CHORROS GOLD MINE

~Mine modernization projected to yield US$12,960,000 of net cash flow to Gemini~

Calgary, AB—Nov. 5 -- Gemini Explorations Inc, (“Gemini”) OTCBB: GXPI, is pleased to report that it has it has increased the cash flow projections for the Los Chorros Gold Mine. On October 25, 2007 Gemini reported vein sample results averaging 41.94 g/tonne Au which has increased the projected production yield from 12 to 20 grams per tonne. MPGS reports that a 100 tonne per day production rate would produce US$1,080,280 monthly and over US$12,900,000 annually. These estimates are based on US$730 per ounce gold with US$200 per ounce operating and production costs netting US$530 per ounce.

The Los Chorros Mine is currently being mined with extremely antiquated equipment and this report further solidifies Gemini’s belief that the project could be turned into a highly efficient producing gold project with low capital costs. Current mining operations at Los Chorros recover a low percentage of the available gold and precious metals present on the property. The plant would initially run at 30 to 50 tonnes/day with a targeted production rate of 100 tonnes per day during the first year. The total cost of the project is estimated to be US$595,900, adding a contingency factor of 30% would bring the maximum projected total to US$774,700.The reports were prepared by general manager Juan Fernando Restrepo and chief geologist Carlos Alberto Vera of Minera Primecap Geological Services (MPGS) of Medellin, Colombia.

Historically one of the largest gold producing countries in the world, Colombia’s vast mineral potential has remained virtually unexplored using modern exploration and mining techniques. The Department (Province/State) of Antioquia alone produces over 1,000,000 ounces of gold per year currently, and most of it is produced from antiquated production equipment and facilities. Driven by a new era of political and economic stability and an investment-friendly mining code, Colombia has emerged as one of the resource sector’s most attractive new mining frontiers.

Notice Regarding Forward Looking Statements

This news release contains "forward-looking statements", as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.  Such forward-looking statements include, among other things, the expectation of the gold production of the property, the expected completion date of the redevelopment and modernization of the Los Chorros Gold mine and the low capital costs to upgrade the Los Chorros operating plant and the net cash flow estimates.Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration.  These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements.  Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate.  Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the 2006 fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Michael Hill

President

Gemini Explorations, Inc

Suite 103, 240-11th Ave SW

Calgary, AB T2R 0C3

http://www.geminiexploration.com/  email: info@geminiexploration.com

IR info: 1 877 700 1644

For an in-depth analyst report, please visit : http://www.smallcapstockanalyst.com/

InfuSystem Holdings, Inc.

(OTC BB:HAPN.OB)

Current Price (4.65)

http://www.smallcapstockanalyst.com/

NEW YORK--Nov. 1--InfuSystem Holdings, Inc. (OTCBB: HAPN - News, HAPNW - News, HAPNU - News), the leading provider of ambulatory infusion pump services for administering chemotherapy, today announced the appointment of Steven E. Watkins as chief executive officer and a member of the board of directors. Mr. Watkins previously served as president of InfuSystem and will replace John Voris as chief executive officer. Mr. Voris will remain a member of the board of directors. As a result, the board will now consist of six directors.         InfuSystem provides external ambulatory infusion pump services to doctors and their patients allowing for the gradual delivery of a drug over a period of days in the privacy of one’s home, rather than higher dose treatments, as is the case of chemotherapy administered in a hospital setting or doctor’s office.

   

Ligand Pharmaceuticals Inc.

(NasdaqGM:LGND)

Current Price (5.00)

http://www.smallcapstockanalyst.com/

SAN DIEGO,Calif. --Nov. 1--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - News) announced today that John L. Higgins, President and Chief Executive Officer and Martin Meglasson, Vice President of Discovery Research, will both present at the Acumen BioFin Rodman & Renshaw Healthcare Conference on Monday, November 5, 2007, at 3:45 p.m. Eastern time (12:45 p.m. Pacific). The conference takes place at The New York Palace Hotel in New York City.                Ligand discovers and develops new drugs that address critical unmet medical needs of patients in the areas of thrombocytopenia, hepatitis C, cancer, hormone-related diseases, osteoporosis and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

Petaquilla Minerals Ltd.

(OTC BB:PTQMF.OB)

Current Price (3.17)

http://www.smallcapstockanalyst.com/

VANCOUVER, BRITISH COLUMBIA--Nov 1, 2007 -- Further to its news release dated October 25, 2007, Petaquilla Minerals Ltd. ("the "Company") (Toronto:PTQ.TO - News)(OTC BB:PTQMF.OB - News)(Frankfurt:P7Z.F - News) announces that it has closed the first tranche of its non-brokered private placement (the "Private Placement"), issuing a total of 2,093,500 Units at a price of $3.00 per Unit and raising gross proceeds of $6,280,500.                   Petaquilla Minerals Ltd. is an emerging gold producer scheduled to bring its 100%-owned Molejon Gold Project into production in fiscal year 2008. Anticipated throughput for the project during the first year of production will be 2200 tonnes per day. The plant will utilize three ball mills and a carbon-in-pulp processing facility.
     

Orchid Cellmark Inc.

(NasdaqGM:ORCH)

Current Price (4.65)

http://www.smallcapstockanalyst.com/

PRINCETON, N.J., Nov. 1 -- Orchid Cellmark Inc. (Nasdaq: ORCH - News), a leading worldwide provider of identity DNA testing services, today reported its financial results for the third quarter of 2007.  Total revenues were $15.6 million for the third quarter of 2007, compared to $15.7 million for the third quarter of 2006, a decrease of 1%. The decrease in revenues was primarily due to lower U.K. agriculture sample testing and to a lesser extent lower U.S. paternity revenues. The overall decrease was essentially offset by higher forensic testing service revenues in the U.S. and U.K.                         
Orchid Cellmark is a leading provider of identity DNA testing services for the human identity and agriculture markets. In the human identity area, the company provides DNA testing services for forensic, family relationship and security applications. In the agriculture field, Orchid Cellmark provides DNA testing services for selective trait breeding. Orchid Cellmark's strong market positions in these areas reflect the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark brand that has been associated with exceptional quality, reliability and customer service for nearly two decades. More information on Orchid Cellmark can be found at www.orchid.com.

SmallCapStockAnalyst.com is owned and operated by Iron Consulting.

Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapStockAnalyst.com is owned and operated by Iron Consulting. Iron Consulting has received seventy one thousand dollars from Equity Alliance Intl. LLC www.equityallianceir.com for a two month internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Market Advisors Inc.

The information and opinions in this report were prepared by Market Advisors Inc. (located in Nebraska) who does receive fees for services including preparation of this report. For this report, officers of Market Advisors Inc received $2,500 from a non-affiliated third party. This is not an offer to buy or sell securities nor should this report be construed as investment advise. Information or statements are subject to numerous risks and uncertainties that cause such statements not to prove accurate. Market Advisors, Inc. does not disseminate, nor is it liable for the dissemination by any third party of this information.